Production (Stage)
Evolent Health, Inc.
EVH
$7.21
-$0.15-2.04%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 483.65M | 646.54M | 621.40M | 647.15M | 639.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 483.65M | 646.54M | 621.40M | 647.15M | 639.65M |
| Cost of Revenue | 381.18M | 570.83M | 540.71M | 540.30M | 535.55M |
| Gross Profit | 102.47M | 75.71M | 80.69M | 106.84M | 104.11M |
| SG&A Expenses | 76.71M | 47.00M | 67.06M | 67.52M | 68.78M |
| Depreciation & Amortization | 24.06M | 29.30M | 29.70M | 29.87M | 29.50M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 481.95M | 647.13M | 637.47M | 637.69M | 633.83M |
| Operating Income | 1.70M | -585.00K | -16.07M | 9.46M | 5.83M |
| Income Before Tax | -63.15M | -23.92M | -23.76M | 1.36M | -16.72M |
| Income Tax Expenses | 1.47M | -1.12M | -619.00K | -238.00K | 565.00K |
| Earnings from Continuing Operations | -64.62M | -22.80M | -23.14M | 1.60M | -17.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.62M | -22.80M | -23.14M | 1.60M | -17.28M |
| EBIT | 1.70M | -585.00K | -16.07M | 9.46M | 5.83M |
| EBITDA | 19.46M | 66.13M | 7.33M | 32.63M | 29.03M |
| EPS Basic | -0.63 | -0.27 | -0.27 | -0.06 | -0.22 |
| Normalized Basic EPS | -0.32 | -0.03 | -0.13 | 0.02 | 0.01 |
| EPS Diluted | -0.63 | -0.27 | -0.27 | -0.06 | -0.22 |
| Normalized Diluted EPS | -0.32 | -0.03 | -0.13 | 0.02 | 0.01 |
| Average Basic Shares Outstanding | 115.32M | 115.03M | 114.86M | 114.69M | 114.14M |
| Average Diluted Shares Outstanding | 115.32M | 115.03M | 114.86M | 114.69M | 114.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -7.08% | -21.08% | -22.19% | 317.48% | -29.39% |